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Introduction
Prostate cancer (PCa) is the second most common cancer 
in men and also ranks fifth among the leading causes of 
death globally. In 2018, 1.3 million new cases of PCa 
were diagnosed and 359,000 associated deaths were 
reported globally [1]. In 2015, PCa also became the most 
common male cancer in the Japanese population  [2]. 
In 2018, 70,654 new cases of PCa were reported and 
the age-standardized rate was 35.4 per 100,000  [3]. 
While the causes of PCa remain to be elucidated, many 
potential risk factors for PCa have been identified. Age, 
race, a high fat diet, alcohol abuse, exposure to cadmium 
or agent orange, and family history are major risk factors 
associated with PCa [4]. Recently, disruption of circadian 
rhythm has also been suggested to be a risk factor for 
carcinogenesis, including development of PCa [5]. The 
incidence of breast and endometrial cancers was higher 
in shift workers who experienced disruption of the 
circadian rhythm [6].
Physiological states such as body temperature, and 
biochemical processes including hormone secretion, 
metabolism, and sleep/wake cycle are controlled by 
circadian rhythms in an approximate 24-hour cycle [7, 8]. 
The suprachiasmatic nucleus (SCN) in the anterior 
hypothalamus of the brain is thought as a central part 
that generate circadian rhythms  [9-11]. The circadian 
rhythms are controlled by the genes, including circadian 
locomotor output cycles kaput (CLOCK), period (PER), 
and cryptochrome (CRY) [9-11].
Some previous research indicated the association between 
various circadian genes and PCa. Wendeu-Foyet et al. 
reported that pathway of 31  circadian genes including 
872 SNPs significantly associated with PCa and this 
association was mainly supported by the circadian core-
genes pathway which were NPAS2 and PER1  [12]. Yu 
et al. also indicated that NPAS2 as a part of circadian 
genes significantly associated with disease progression 
of PCa  [13]. Other article showed that some circadian 
genes (PER1, PER2, CRY1, CRY2, CLOCK, NPAS2) 
were significantly associated with susceptibility to 
prostate cancer [14]. On the other hand, circadian genes 
could play a part of role of carcinogenesis or the tumor 
suppressor through cell proliferation and apoptosis [15]. 
These findings indicated there was a potential link 
between genetic variants in circadian genes and PCa.
PER is one of the main mediators of the circadian rhythm, 
and has a function in the negative feedback loop where it is 
translocated from the cytoplasm to the nucleus to regulate 
their expression by an inhibit transcription [16, 17]. PER 
has three paralogs, PER1, PER2, and PER3. Disruption 
of the circadian genes, including that of PER3, affects 
carcinogenesis related cellular processes, including 
proliferation, cell cycle regulation, and apoptosis  [18]. 
PER3 expression was decreased in chronic myeloid 
leukemia  [19], and expression of PER3 in colorectal 
cancer tissue was lower than in healthy mucosa [18, 20]. 
Polymorphisms of PER3 have also been associated with 
various cancers [14, 21, 22].
The rs2640908 polymorphism is a PER3 single 
nucleotide polymorphism (SNP) associated with cancer 
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development  [23-25]. The rs2640908 polymorphism 
has an association with patient overall survival in 
hepatocellular carcinoma and colorectal carcinoma. 
Another polymorphism of PER3 is a variable number 
tandem repeat (VNTR) consisting of 4-5 repeat 54-bp 
sequences in exon 18 encoding 18 amino acids  [26]. 
Individuals with a variant of 5 VNTR repeats experience 
delayed sleep phase syndrome and extreme diurnal 
preference  [27,  28]. A relationship between VNTR 
polymorphism and elevated levels of serum cytokine 
IL-6 has also been reported  [29]. This suggested that 
PER3 polymorphisms could have an influence on the 
carcinogenesis through cell cycle regulation. However, 
the relationship between both rs2640908 and VNTR 
polymorphisms and PCa in the Japanese population is 
yet to be studied in detail. Thus, the aim of this study 
was to evaluate the relationship between rs2640908 and 




A total of 83 patients with PCa and 122 healthy controls 
were recruited from the Japanese population. Patients 
were diagnosed at the University of Occupational and 
Environmental Health (UOEH) Hospital and University 
of Miyazaki Hospital in Japan, and all diagnoses were 
confirmed by histology. The control subjects were 
recruited from UOEH Hospital, University of Miyazaki 
Hospital, and a hospital located near UOEH Hospital.
All subjects were surveyed with self–questionnaires that 
collected information on history of illness, occupation, 
and smoking status. Participants who had been exposed 
to carcinogenic agents, heavy metals, and radiation in 
their occupational history were excluded. The included 
subjects were classified into two groups according to 
smoking status. The non-smokers were grouped into the 
“Never” group, and both current and previous smokers 
were classified as “Smoker”. All participants were 
briefed about the study, and written informed consent 
was obtained from each participant. This study was 
approved by the Ethics Committee of the Faculty of 
Medicine, University of Miyazaki.
Genotyping
Peripheral blood samples were collected from each 
subject, and genomic DNA was extracted by proteinase 
K digestion and phenol/chloroform extraction 
method [30].
Genotyping of the rs2640908 polymorphism 
was carried out using PCR-Restriction Fragment 
Length Polymorphism (PCR-RFLP). The sequence 
of PCR primers used for amplification were 
5 ’ - C T G T T TA AC AC AC G A AG T T G A AG A - 3 ’ 
(forward) and 5’-GTTCTGGATGGGGATTCGCT-3’ 
(reverse). PCR was performed using a KAPATaq EXtra 
PCR Kit (NIPPON Genetics Co., Ltd., Tokyo, Japan) 
following manufacturer’s instructions. The thermocycler 
conditions were: initial denaturation at 94˚C for 2 min, 
followed by 35 cycles of denaturation at 94˚C for 
30 s, annealing at 55˚C for 30 s, and extension at 72˚C 
for 45  s, with final extension at 72˚C for 7 min. PCR 
products were digested with AgeI restriction enzyme 
(New England Biolabs Inc., Ipswich, MA, USA) and 
incubated at 37˚C overnight, before being resolved by 
2% agarose gel electrophoresis. For genotyping, two 
digestion products of size 798 and 265 bp were expected 
for C/C genotype (homozygous wild-type), three 
products of size 1,063, 798, and 265 bp were expected 
for C/T genotype, and only a single product sized 1,063 
bp was expected for T/T genotype. The electrophoretic 
image of each genotypes is shown in Figure 1.
PCR genotyping for VNTR polymorphisms was similarly 





The thermocycler conditions were: initial denaturation at 
94˚C for 2 min, followed by 35 cycles of denaturation at 
94 ˚C for 30 s, annealing at 60˚C for 30 s, and extension at 
72˚C for 45 s with at final extension at 72˚C for 7 min. A 
4/4 genotype (homozygous for 4 repeats) had an expected 
product size of 581 bp, 4/5 (heterozygotes) had expected 
product sizes of 635 and 581bp, 5/5 (homozygous for 
5 repeats) had an expected product size of 635 bp (Fig. 1). 
PCR products were resolved and visualized using 2% 
agarose gel electrophoresis.
Statistical analysis
A t-test was used to compare the continuous variables, 
and a χ2 test was used to compare categorical data and 
to determine probability of allele frequencies being in 
Hardy–Weinberg equilibrium [31]. Odds ratio (OR) and 
95% confidence interval (95% CI) were estimated using a 
multiple logistic regression analysis with adjustment for 
age and smoking status. Stratified analysis by smoking 
status was also performed. The level of statistical 
significance was set at P value  <  0.05. All statistical 
analyses were performed using R ver. 3.6.1.
Results
Clinical characteristics of patient and control subjects, 
including age and smoking status, are summarized in 
Table  I. The mean age was 69.2 years (SD:  10.4) for 
control group and 71.6 years (SD: 8.6) for the patient 
group. Incidentally, a significantly higher percentage of 
the control group (83.6%) was classified as “Smoker” 
compared to the patient group (67.5%, P = 0.01).
Distribution of rs2640908 and VNTR polymorphisms for 
patient and control groups are shown in Table II. Allele 
frequencies for rs2640908 and VNTR polymorphisms in 
the control group were in Hardy-Weinberg equilibrium 
(P  =  0.86 and 0.76, respectively). For rs2640908 
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genetic variants, risk for PCa was significantly lower 
for T/T genotype (adjusted OR:  0.35, 95%  CI:  0.15-
0.81,  P  =  0.02), and C/T + T/T genotype (adjusted 
OR: 0.46, 95% CI: 0.24-0.88, P = 0.02) relative to the 
C/C genotype, with no significant difference observed 
for C/T genotype (adjusted OR:  0.52, 95%  CI: 0.26-
1.03, P  =  0.06). In contrast, no significant association 
was observed between any of the VNTR variants and 
PCa.
Table  III shows the analysis stratified by smoking 
status. For rs2640908 polymorphisms in the “Smoker” 
group, there was a significantly lower risk of PCa in 
T/T genotype (adjusted OR: 0.29, 95% CI: 0.10-0.77, 
P  =  0.02) and C/T + T/T (adjusted OR: 0.47, 95% 
Tab. I. Characteristics of the controls and cases.
Variable Controls (n = 122) Cases (n = 83) P-value
Age
Mean (SD) 69.2 (10.4) 71.6 (8.6) 0.08
Smoking status (%)
Never 20 (16.4) 27 (32.5)
0.01
Smoker 102 (83.6) 56 (67.5)
t-test and χ2 test were used for age and smoking status, respectively.











C/C (%) 26 (21.3) 29 (34.9) Ref Ref
C/T (%) 63 (51.6) 40 (48.2) 0.57 (0.29-1.10) 0.52 (0.26-1.03)
T/T (%) 33 (27.0) 14 (16.9) 0.38 (0.16-0.85)* 0.35 (0.15-0.81)*
C/T + T/T (%) 96 (78.7) 54 (65.1) 0.50 (0.27-0.94)* 0.46 (0.24-0.88)*
VNTR
4/4 (%) 82 (67.2) 56 (67.5) Ref Ref
4/5 (%) 37 (30.3) 25 (30.1) 0.99 (0.53-1.82) 0.94 (0.50-1.76)
5/5 (%) 3 (2.5) 2 (2.4) 0.98 (0.13-6.07) 1.28 (0.16-8.69)
4/5 + 5/5 (%) 40 (32.8) 27 (32.5) 0.99 (0.54-1.79) 0.96 (0.52-1.77)
χ2 test and multiple logistic regression were used for crude OR and adjusted OR for age and smoking status, respectively. 95% CI: 95% confidence interval; 
OR: odds ratio; Ref: reference; *: P < 0.05.












C/C (%) 3 (15.0) 8 (29.6) Ref Ref
C/T (%) 11 (55.0) 12 (44.4) 0.41 (0.07-1.83) 0.39 (0.07-1.76)
T/T (%) 6 (30.0) 7 (25.9) 0.44 (0.07-2.34) 0.53 (0.08-3.02)
C/T + T/T (%) 17 (85.0) 19 (70.4) 0.42 (0.08-1.72) 0.43 (0.08-1.79)
VNTR
4/4 (%) 12 (60.0) 20 (74.1) Ref Ref
4/5 (%) 8 (40.0) 6 (22.2) 0.45 (0.12-1.60) 0.40 (0.10-1.46)
5/5 (%) 0 (0) 1 (3.7) - -
4/5 + 5/5 (%) 8 (40.0) 7 (25.9) 0.53 (0.15-1.81) 0.48 (0.13-1.70)
Smoker
rs2640908
C/C (%) 23 (22.5) 21 (37.5) Ref Ref
C/T (%) 52 (51.0) 28 (50.0) 0.59 (0.28-1.25) 0.57 (0.27-1.21)
T/T (%) 27 (26.5) 7 (12.5) 0.28 (0.10-0.76)* 0.29 (0.10-0.77)*
C/T + T/T (%) 79 (77.5) 35 (62.5) 0.49 (0.24-0.99)* 0.47 (0.23-0.97)*
VNTR
4/4 (%) 70 (68.6) 36 (64.3) Ref Ref
4/5 (%) 29 (28.4) 19 (33.9) 1.27 (0.62-2.57) 1.22 (0.60-2.48)
5/5 (%) 3 (2.9) 1 (1.8) 0.65 (0.03-5.27) 0.81 (0.04-6.97)
4/5 + 5/5 (%) 32 (31.4) 20 (35.7) 1.22 (0.61-2.41) 1.19 (0.59-2.37)
χ2 test and multiple logistic regression were used for crude OR and adjusted OR for age, respectively. 95% CI: 95% confidence interval; OR: odds ratio; 
Ref: reference; *: P < 0.05.
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CI: 0.23-0.97, P = 0.04) compared to the C/C genotype. 
Again, no relationship was observed between VNTR 
genotypes and PCa.
Discussion
In this study, we studied the relationship between the 
PER3 polymorphisms, rs2640908 and VNTR, and risk 
of PCa in the Japanese population. We demonstrated 
that for the rs2640908 polymorphism, the T/T and 
C/T + T/T genotypes are associated with a lower risk 
of PCa. However, we were unable to find a significant 
association between VNTR variants and PCa.
Disruption of the circadian rhythm is linked to an increased 
risk of several diseases, including cancer  [18-20,  32]. 
Disruption can arise from different factors, such as shift 
work and exposure to light at night (LAN exposure) [33]. 
Shift work influences body temperature, energy 
allocation, and disrupts circadian rhythm, resulting in 
damage to health. The circadian rhythm is a physiological 
fluctuation that takes place in approximately 24-hour 
cycles, and is involved in the health and survival of most 
living organisms. Some reports have described auto–
regulatory transcriptional and translational feedback loop 
mechanisms for circadian genes, with both positive and 
negative regulators [34]. Circadian genes have also been 
linked to carcinogenesis through DNA repair, apoptosis, 
and cell proliferation [15, 35, 36].
PER is a circadian gene, with 3 subtypes (PER1, PER2, 
and PER3)  [14]. A previous study has suggested that 
heterozygosity of a PER3 polymorphism could be a 
risk factor for breast cancer among premenopausal 
women  [26]. PER3 also plays an important role in 
regulating cell proliferation and apoptosis [37]. Deletion 
and reduced expression of PER3 results in upregulation 
of the estrogen receptors, and is associated with an 
increased recurrence of breast cancer  [38], suggesting 
that the PER3 may also play a role in homeostasis for 
reproductive hormones.
There are two polymorphisms described for PER3, 
rs2640908 and VNTR. At least one variant allele 
of the rs2640908 polymorphism is associated with 
a significantly lower risk of death among patients 
with hepatocellular carcinoma when compared 
to homozygous wild-type patients  [24]. The T/T 
genotype of the rs2640908 polymorphism also has a 
protective effect in colorectal cancer compared to the 
C/C genotype [25]. We found a similar effect for PCa. 
However, the biological mechanisms that underlie 
this protection against carcinogenesis remain to be 
elucidated. The rs2640908 polymorphism is found in 
the exonic splicing enhancer (ESE) region, which can 
affect or alter translation initiation sites and translation 
efficiencies through mRNA splicing, and destabilize the 
binding of the serine/arginine-rich (SR) protein [39]. The 
rs2640908 polymorphism may therefore reduce exon 
recognition and define an alternative splice site  [40]. 
This would affect cell proliferation, cell cycle regulation, 
and apoptosis, potentially leading to cancer [25].
In our study, no correlation was observed between 
VNTR polymorphisms and PCa. Varying relationships 
between VNTR polymorphism and carcinogenesis 
have been reported previously. The VNTR variant with 
5 repeats is associated with increased risk of prostate 
cancer in men with high levels of insulin resistance [41] 
and with colorectal adenoma [21]. In contrast, a meta-
analysis could not identify any significant relationships 
between VNTR polymorphisms and breast, prostate, 
and colon cancers  [42]. The 5 repeats sequence of the 
VNTR polymorphism play an essential role as it is 
a phosphorylation site, and the 5/5 genotype plays a 
crucial role in the circadian process compared to the 4/4 
genotype [43]. Heritable chronotypes may be polygenic, 
and variants of several genes may be required for full 
phenotypic expression  [43]. That may explain why no 
association was observed between VNTR polymorphism 
and PCa in this study.
There relation between circadian genes and PCa was 
inconsistent. Markt et al. did not find the consistent 
association between 96 SNPs across 12 circadian-related 
genes and fatal prostate cancer risk using three patient 
cohorts [44]. On the other hand, the study on EPICAP 
study showed the evidence supporting hypothesis of 
a link between circadian genes and PCa  [12]. Since 
circadian rhythms were produced by multiple molecular 
interactions of protein, and PCa was a complex polygenic 
trait, a single-SNP approach may not be sufficient to 
investigate the association between circadian genes and 
PCa [12]. Therefore, further investigation will be need 
to evaluate the relation between circadian genes and 
carcinogenesis of PCa with more samples and various 
genes including PER3 gene, especially for Japanese 
population.
We also evaluated the association between rs2640908 
polymorphisms and susceptibility to PCa in smokers. We 
found that the T/T and C/T + T/T genotypes conferred 
lower risk of PCa compared to the C/C genotype within the 
“Smoker” group, but not the “Never” group. This result 
suggests that there is an association between smoking 
and PER3 polymorphisms, as previously observed in 
colon cancer  [25]. Cigarette exposure changes DNA 
binding by modulating the redox potential of cells and 
tissues [45], and therefore affects transcriptional activity. 
Binding of transcriptional circadian genes, including 
BMAL1, CLOCK, and NPAS2, is dependent on the redox 
ratio [46]. Circadian genes and smoking may therefore 
interact in a synergistic manner. However, the possibility 
of association between gene polymorphisms and 
smoking remains controversial. Jin et al has advocated 
that genetic differences in risk tend to be smaller at 
high doses of carcinogens, including tobacco, when 
the environmental effect may overpower any genetic 
predisposition  [47]. However, this was disputed by 
Kuroda et al, who reported that the Pro/Pro genotype of a 
TP53 polymorphism in smokers was significantly higher 
in patients with urothelial cancer compared with that in 
the control [48]. Polymorphisms for the metabolic genes 
GSTT1, GSTM1, and CYP1A1 are not associated with 
the smoking status in onco-hematological diseases [49]. 
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Considering these contradictory findings, further studies 
are warranted to clearly elucidate the relationships 
between gene polymorphisms and smoking.
There were some limitations to this study. First, our small 
sample may have induced a sampling bias and affected 
the results of the stratified analysis. Secondly, we had no 
information regarding the history of shift work, alcohol 
consumption, BMI, sleep time, clinical characteristics, 
smoking period and number of cigarettes. The lack of 
these data also induced information bias, and introduced 
the influence to our results. Especially, since circadian 
genes polymorphism could influence sleep condition 
and shift work tolerance  [50], the interaction with 
circadian genes and sleep condition (sleep duration and 
sleep quality) could influence the carcinogenesis of PCa. 
Therefore, additional study will be needed to evaluate 
the relation between PER3 gene polymorphisms and 
carcinogenesis of PCa with considering sleep condition.
We could not use smoking condition (smoking period 
and number of cigarettes), but used the status of 
smoking. We found that the rate of smoking was higher 
in the control than in the patient group. We estimated 
the interaction with smoking and PER3 polymorphism 
(rs2640908) by multiple logistic regression analysis. 
Therefore, smoking condition (smoking period and 
number of cigarettes) could be important factor. It 
would be necessary to evaluate the relation between 
smoking condition and PER3 polymorphism stratified 
by smoking condition. Despite these limitations, we 
believe our findings provide a basis for future studies 
investigating the association between prostate cancer 
and circadian gene polymorphisms.
Conclusions
In conclusion, this is the first study that focused on 
associations between PER3 polymorphisms (rs2640908 
and VNTR) and PCa risk. For rs2640908, the T/T and 
C/T + T/T genotypes had a significant protective effect 
against PCa in the Japanese population. However, 
no relationship between VNTR polymorphisms and 
PCa could be detected. Our finding suggests that the 
rs2640908 polymorphism may be a useful marker for 
prostate cancer and contributes to further understanding 




SNP: Single Nucleotide Polymorphism.
VNTR: Variable Number Tandem Repeat.
PCR: Polymerase Chain Reaction.
PCR-RFLP: Polymerase Chain Reaction - Restriction 
Fragment Length Polymorphism. 





PER2: Period 2. 
PER3: Period 3.
IL-6: Interleukin-6. 
UOEH: University of Occupational and Environmental 
Health.
AgeI: Restriction Enzyme.
χ2 test: Chi-square test.
OR: Odds Ratio.
95% CI: 95% Confidence Interval.
SD: Standard Deviation.
LAN exposure: Light at Night Exposure.
IARC: The Agency for Research on Cancer.
DNA: Deoxyribonucleic Acid.
ESE: Exonic Splicing Enhancer.
mRNA: Messenger Ribonucleic Acid.
SR: Serine/Arginine-Rich.
BMAL1: Brain and Muscle Arnt - Like 1.
NPAS2: Neuronal PAS domain 2.
TP53: Tumor Protein 53. 
GSTT1: Glutathione S - transferase theta 1.
GSTM1: Glutathione S - transferase Mu 1. 
CYP1A1: Cytochrome P450 Family 1 Subfamily A 
Member 1.
Acknowledgements
Funding sources: this research did not receive any spe-
cific grant from funding agencies in the public, commer-
cial, or not-for-profit sectors.
The authors are indebted to the participants in the present 
study.
Conflict of interest statement
The authors declare no conflict of interest.
Authors’ contributions
TH contributed to experimental work and designed 
the experiments and analyzed the results. SM and TK 
contributed in the data collection. YK contributed 
on interpreted, reviewed the experiment design, and 
critically reviewed the manuscript. All authors reviewed 
the manuscript and approved the final draft.
References
[1] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Je-
mal A. Global cancer statistics 2018: GLOBOCAN estimates 
of incidence and mortality worldwide for 36 cancers in 185 
countries. CA Cancer J Clin 2018;68:394-424. https://doi.
org/10.3322/caac.21492
[2] Center for Cancer Control and Information Services NCC. 
Projected Cancer Statistics. 2015. Available: http://ganjoho.jp/
reg_stat/statistics/stat/short_pred.html
[3] International Agency for Research Center. Global Can-
T. HINOURA ET AL.
E494






[4] Verma M, Patel P, Verma M. Biomarkers in prostate cancer 
epidemiology. Cancers (Basel) 2011;3:3773-98. https://doi.
org/10.3390/cancers3043773
[5] Wendeu-Foyet MG, Menegaux F. Circadian disruption and 
prostate cancer risk: an updated review of epidemiological evi-
dences. Cancer Epidemiol Biomarkers Prev 2017;26:985-91. 
https://doi.org/10.1158/1055-9965.EPI-16-1030
[6] Straif K, Baan R, Grosse Y, Secretan B, Ghissassi F El, Bouvard 
V, Altieri A. Carcinogenicity of shift-work , painting , and fire-
fighting. Lancet Oncol 2007;8:1065-6. 
[7] Dibner C, Schibler U, Albrecht U. The mammalian circadian 
timing system: organization and coordination of central and pe-
ripheral clocks. Annual Review of Physiology 2010;72:517-49. 
https://doi.org/10.1146/annurev-physiol-021909-135821
[8] Lowrey PL, Takahashi JS. Mammalian circadian biology: eluci-
dating genome-wide levels of temporal organization. Annu Rev 
Genomics Hum Genet 2004;5:407-41. https://doi.org/10.1146/
annurev.genom.5.061903.175925
[9] Kondratov RV, Chernov MV, Kondratova AA, Gorbacheva VY, 
Gudkov AV, Antoch MP. BMAL1-dependent circadian oscilla-
tion of nuclear CLOCK: posttranslational events induced by di-
merization of transcriptional activators of the mammalian clock 
system. Genes Dev 2003;17:1921-32. https://doi.org/10.1101/
gad.1099503
[10] DeBruyne JP, Weaver DR, Reppert SM. CLOCK and NPAS2 
have overlapping roles in the suprachiasmatic circadian clock. 
Nat Neurosci 2007;10:543-5. https://doi.org/10.1038/nn1884
[11] Asher G, Schibler U. A clock-less clock. Trends Cell Biol 
2006;16:547-9. https://doi.org/10.1016/j.tcb.2006.09.005
[12] Wendeu-Foyet MG, Koudou Y, Cénée S, Trétarre B, Rébillard 
X, Cancel-Tassin G, Cussenot O, Boland A, Bacq D, Deleuze 
JF, Lamy PJ, Mulot C, Laurent-Puig P, Truong T, Menegaux 
F. Circadian genes and risk of prostate cancer: findings from 
the EPICAP study. Int J Cancer 2019;145:1745-53. https://doi.
org/10.1002/ijc.32149
[13] Yu CC, Chen LC, Chiou CY, Chang YJ, Lin VC, Huang CY, 
Lin IL, Chang TY, Lu TL, Lee CH, Huang SP, Bao BY. Genetic 
variants in the circadian rhythm pathway as indicators of pros-
tate cancer progression. Cancer Cell Int 2019;19:1-9. https://
doi.org/10.1186/s12935-019-0811-4
[14] Zhu Y, Stevens RG, Hoffman AE, FitzGerald LM, Kwon EM, 
Ostrander EA, Davis S, Zheng T, Stanford JL. Testing the cir-
cadian gene hypothesis in prostate cancer: a population-based 
case-control study. Cancer Res 2009;69:9315-22. https://doi.
org/10.1158/0008-5472.CAN-09-0648
[15] Fu L, Lee CC. The circadian clock: pacemaker and tumour sup-
pressor. Nat Rev Cancer 2003;3:350-61. https://doi.org/10.1038/
nrc1072
[16] Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin 
X, Maywood ES, Hastings MH, Reppert SM. mCRY1 and 
mCRY2 are essential components of the negative limb of the 
circadian clock feedback loop. Cell 1999;98:193-205. https://
doi.org/10.1016/S0092-8674(00)81014-4
[17] Dunlap JC. Molecular bases for circadian clocks. Cell 1999;96:271-
90. https://doi.org/10.1016/S0092-8674(00)80566-8
[18] Wang X, Yan D, Teng M, Fan J, Zhou C, Li D, Qiu G, Sun 
X, Li T, Xing T, Tang H, Peng X, Peng Z. Reduced expres-
sion of PER3 is associated with incidence and development 
of colon cancer. Ann Surg Oncol 2012;19:3081-8. https://doi.
org/10.1245/s10434-012-2279-5
[19] Yang MY, Chang JG, Lin PM, Tang KP, Chen YH, Lin HYH, 
Liu TC, Hsiao HH, Liu YC, Lin SF. Downregulation of cir-
cadian clock genes in chronic myeloid leukemia: alternative 
methylation pattern of hPER3. Cancer Sci 2006;97:1298-307. 
https://doi.org/10.1111/j.1349-7006.2006.00331.x
[20] Oshima T, Takenoshita S, Akaike M, Kunisaki C, Fujii S, No-
zaki A, Numata K, Shiozawa M, Rino Y, Tanaka K, Masuda 
M, Imada T. Expression of circadian genes correlates with 
liver metastasis and outcomes in colorectal cancer. Oncol Rep 
2011;25:1439-46. https://doi.org/10.3892/or.2011.1207
[21] Alexander M, Burch JB, Steck SE, Chen CF, Hurley TG, Cavic-
chia P, Ray M, Shivappa N, Gues J, Zhang H, Youngstedt SD, 
Crek KE, Lloyd S, Yang X, Hébert JR. Case-control study of 
the PERIOD3 clock gene length polymorphism and colorectal 
adenoma formation. Oncol Rep 2015;33:935-41. https://doi.
org/10.3892/or.2014.3667
[22] Zienolddiny S, Haugen A, Lie J-AS, Kjuus H, Anmarkrud KH, 
Kjaerheim K. Analysis of polymorphisms in the circadian-re-
lated genes and breast cancer risk in Norwegian nurses work-
ing night shifts. Breast Cancer Res 2013;15:R53. https://doi.
org/10.1186/bcr3445
[23] Qu F, Qiao Q, Wang N, Ji G, Zhao H, He L, Wang H, Bao G. 
Genetic polymorphisms in circadian negative feedback regula-
tion genes predict overall survival and response to chemothera-
py in gastric cancer patients. Sci Rep 2016;6:22424. https://doi.
org/10.1038/srep22424
[24] Zhao B, Lu J, Yin J, Liu H, Guo X, Yang Y, Ge N, Zhu Y, 
Zhang H, Xing J. A functional polymorphism in PER3 gene 
is associated with prognosis in hepatocellular carcinoma. 
Liver Int 2012;32:1451-9. https://doi.org/10.1111/j.1478-
3231.2012.02849.x
[25] Holipah, Hinoura T, Kozaka N, Kuroda Y. The correlation be-
tween PER3 rs2640908 polymorphism and colorectal Cancer in 
the Japanese population. Appl Cancer Res 2019;39:4-9. https://
doi.org/10.1186/s41241-019-0072-5
[26] Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T. Period3 
structural variation: a circadian biomarker associated with 
breast cancer in young women. Cancer Epidemiol Biomarkers 
Prev 2005;14:268-70. https://doi.org/14/1/268 [pii]
[27] Archer SN, Robilliard DL, Skene DJ, Smits M, Williams A, 
Arendt J, Von Schantz M. A length polymorphism in the circa-
dian clock gene Per3 is linked to delayed sleep phase syndrome 
and extreme diurnal preference. Sleep 2003;26:413-5. https://
doi.org/10.1093/sleep/26.4.413
[28] Ebisawa T, Uchiyama M, Kajimura N, Mishima K, Kamei Y, 
Katoh M, et al. Association of structural polymorphisms in the 
human period3 gene with delayed sleep phase syndrome. EM-
BO Rep 2001;2:342-6. https://doi.org/10.1093/embo-reports/
kve070
[29] Guess J, Burch JB, Ogoussan K, Armstead CA, Zhang H, Wag-
ner S, Hebert JR, Wood P, Youngstedt SD, Hofseth LJ, Singh 
UP, Xie D, Hrushesky WLM. Circadian disruption, Per3, and 
human cytokine secretion. Integr Cancer Ther 2009;8:329-36. 
https://doi.org/10.1177/1534735409352029
[30] Yamauchi T, Takeuchi S, Maehara N, Kuroda Y. The genotype 
of the transporter associated with antigen processing gene af-
fects susceptibility to colorectal cancer in Japanese. Environ 
Health Prev Med 2014;19:265-70. https://doi.org/10.1007/
s12199-014-0388-4
[31] Graffelman J. Exploring diallelic genetic markers: the Hardy-
Weinberg Package. J Stat Softw 2015;64:1-23. Available: htt-
ps://www.jstatsoft.org/article/view/v064i03
[32] Huang XL, Fu CJ, Bu RF. Role of circadian clocks in the devel-
opment and therapeutics of cancer. J Int Med Res 2011;39:2061-
6. https://doi.org/10.1177/147323001103900601
[33] Reszka E, Wieczorek E, Przybek M, Jabłońska E, Kałużny P, 
Bukowska-Damska A, Zienolddiny S, Pepłońska B. Circadian 
gene methylation in rotating-shift nurses: a cross-sectional 
study. Chronobiol Int 2018;35:111-21. https://doi.org/10.1080
/07420528.2017.1388252
[34] Masri S, Zocchi L, Katada S, Mora E, Sassone-Corsi P. The cir-
GENETIC POLYMORPHISMS AND CANCER RISK
E495
cadian clock transcriptional complex: metabolic feedback inter-
sects with epigenetic control. Ann N Y Acad Sci 2012;1264:103-
9. https://doi.org/10.1111/j.1749-6632.2012.06649.x
[35] Reddy AB, Wong GKY, O’Neill J, Maywood ES, Hastings MH. 
Circadian clocks: neural and peripheral pacemakers that impact 
upon the cell division cycle. Mutat Res - Fundam Mol Mech 
Mutagen 2005;574:76-91. https://doi.org/10.1016/j.mrfm-
mm.2005.01.024
[36] Kondratov R V., Gorbacheva VY, Antoch MP. The role of mam-
malian circadian proteins in normal physiology and genotoxic 
stress responses. Curr Top Dev Biol 2007;78:173-216. https://
doi.org/10.1016/S0070-2153(06)78005-X
[37] Im JS, Jung BH, Kim SE, Lee KH, Lee JK. Per3, a circadian 
gene, is required for Chk2 activation in human cells. FEBS Lett 
2010;584:4731-4. https://doi.org/10.1016/j.febslet.2010.11.003
[38] Climent J, Perez-Losada J, Quigley DA, Kim IJ, Delrosario 
R, Jen KY, Bosch A, Lluch A, Mao JH, Balmain A. Deletion 
of the PER3 gene on chromosome 1p36 in recurrent ER-pos-
itive breast cancer. J Clin Oncol 2010;28:3770-8. https://doi.
org/10.1200/JCO.2009.27.0215
[39] Tan W, Wang W, Ma Q. Physiological and pathological function of 
serine/arginine-rich splicing factor 4 and related diseases. Biomed 
Res Int 2018;3819719. https://doi.org/10.1155/2018/3819719
[40] Yamaguchi S, Shinmura K, Saitoh T, Takenoshita S, Ku-
wano H, Yokota J. A single nucleotide polymorphism at the 
splice donor site of the human MYH base excision repair 
gene results in reduced translation efficiency of its transcripts. 
Genes to Cells 2002;7:461-74. https://doi.org/10.1046/j.1365-
2443.2002.00532.x
[41] Chu LW, Zhu Y, Yu K, Zheng T, Yu H, Zhang Y, Sesterhenn I, 
Chokkalingam AP, Danforth KN, Shen MC, Stanczyk FZ, Gao 
YT, Hsing AW. Variants in circadian genes and prostate cancer 
risk: a population-based study in China. Prostate Cancer Prostat-
ic Dis 2008;11:342-8. https://doi.org/10.1038/sj.pcan.4501024
[42] Geng P, Ou J, Li J, Wang N, Xie G, Sa R, Liu C, Xiang L, Liang 
H. Genetic association between PER3 genetic polymorphisms 
and cancer susceptibility. Med (United States) 2015;94:1-6. 
https://doi.org/10.1097/MD.0000000000000568
[43] Wirth MD, Burch JB, Hébert JR, Kowtal P, Mehrotra-Kapoor 
A, Steck SE, Hurley TG, Gupta PC, Pednekar MS, Youngstedt 
SD, Zhang H, Sarin R. Case-control study of breast cancer in 
India: role of PERIOD3 clock gene length polymorphism and 
chronotype. Cancer Invest 2014;32:321-9. https://doi.org/10.31
09/07357907.2014.919305
[44] Markt SC, Valdimarsdottir UA, Shui IM, Sigurdardottir LG, 
Rider JR, Tamimi RM, Batista JL, Haneuse S, Flynn- E, Lock-
ley SW, Czeisler CA, Stampfer MJ, Harris T, Smith AV, Gud-
nason V. Circadian clock genes and risk of fatal prostate cancer. 
NIH Public Access 2015;26:25-33. https://doi.org/10.1007/
s10552-014-0478-z.Circadian
[45] Ebel GS, Gerstmayer B, Kuhl P, Borlak J, Meurrens K, Müller 
T. The kinetics of transcriptomic changes induced by cigarette 
smoke in rat lungs reveals a specific program of defense, in-
flammation, and circadian clock gene expression. Toxicol Sci 
2006;93:422-31. https://doi.org/10.1093/toxsci/kfl071
[46] Rutter J, Reick M, Wu LC, McKnight SL. Regulation of crock 
and NPAS2 DNA binding by the redox state of NAD cofac-
tors. Science 2001;293:510-4. https://doi.org/10.1126/sci-
ence.1060698
[47] Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, Honn 
SE, Spitz MR. Higher lung cancer risk for younger African-
americans with the pro/pro p53 genotype. Carcinogenesis 
1995;16:2205-8. https://doi.org/10.1093/carcin/16.9.2205
[48] Kuroda Y, Tsukino H, Nakao H, Imai H, Katoh T. P53 Co-
don 72 polymorphism and urothelial cancer risk. Can-
cer Lett 2003;189:77-83. https://doi.org/10.1016/S0304-
3835(02)00518-9
[49] Cerliani MB, Pavicic W, Gili JA, Klein G, Saba S, Richard S. 
Cigarette smoking, dietary habits and genetic polymorphisms 
in GSTT1 , GSTM1 and CYP1A1 metabolic genes: a case-con-
trol study in oncohematological diseases. World J Clin Oncol 
2016;7:395-405. https://doi.org/10.5306/wjco.v7.i5.395
[50] Taniyama Y, Yamauchi T, Takeuchi S, Kuroda Y. PER1 polymor-
phism associated with shift work disorder. Sleep Biol Rhythms 
2015;13:342-7. https://doi.org/10.1111/sbr.12123
Received on November 13, 2020. Accepted on April 18, 2021.
Correspondence: Yoshiki Kuroda, Department of Public Health, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake-cho, 
Miyazaki city, Miyazaki 889-1692, Japan - Tel.: +81-985-85-0874 - Fax: +81-985-85-6258 - E-mail: ykuroda@med.miyazaki-u.ac.jp
How to cite this article: Hinoura T, Mukai S, Kamoto T, Kuroda Y. PER3 polymorphisms and their association 
with prostate cancer risk in Japanese men. J Prev Med Hyg 2021;62:E584-E495. https://doi.org/10.15167/2421-4248/jpmh2021.62.2.1865
© Copyright by Pacini Editore Srl, Pisa, Italy
This is an open access article distributed in accordance with the CC-BY-NC-ND (Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International) licen-
se. The article can be used by giving appropriate credit and mentioning the license, but only for non-commercial purposes and only in the original version. For further 
information: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en
